Does TACROLIMUS Cause Product substitution issue? 148 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 148 reports of Product substitution issue have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.2% of all adverse event reports for TACROLIMUS.
148
Reports of Product substitution issue with TACROLIMUS
0.2%
of all TACROLIMUS reports
1
Deaths
27
Hospitalizations
How Dangerous Is Product substitution issue From TACROLIMUS?
Of the 148 reports, 1 (0.7%) resulted in death, 27 (18.2%) required hospitalization, and 7 (4.7%) were considered life-threatening.
Is Product substitution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 148 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Product substitution issue?
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832)
BUPROPION (1,578)
METHYLPHENIDATE (1,408)
CLONAZEPAM (1,288)
LAMOTRIGINE (979)
ALBUTEROL (864)
LEVOTHYROXINE (803)
DULOXETINE (766)
ESTRADIOL (692)
SERTRALINE (636)
Which TACROLIMUS Alternatives Have Lower Product substitution issue Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB